In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease?

by Raphael Mohr, Burcin Özdirik, Jana Knorr, Alexander Wree, Münevver Demir, Frank Tacke, Christoph Roderburg
Published 2020-07-01

Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors.

by Teresa Hellberg, Raphael Mohr, Lukas Geisler, Jana Knorr, Alexander Wree, Münevver Demir, Fabian Benz, Joeri Lambrecht, Sven H Loosen, Frank Tacke, Christoph Roderburg, Henning Jann, Burcin Özdirik
Published 2020-01-01

The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors

by Lukas Geisler, Raphael Mohr, Joeri Lambrecht, Jana Knorr, Henning Jann, Sven H. Loosen, Burcin Özdirik, Tom Luedde, Linda Hammerich, Frank Tacke, Alexander Wree, Teresa Hellberg, Christoph Roderburg
Published 2021-08-01

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies

by Burcin Özdirik, Anna Stueven, Jana Knorr, Lukas Geisler, Raphael Mohr, Münevver Demir, Teresa Hellberg, Sven H. Loosen, Fabian Benz, Bertram Wiedenmann, Frank Tacke, Alexander Wree, Henning Jann, Christoph Roderburg
Published 2020-05-01

Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study

by Burcin Özdirik, Anna K. Stueven, Raphael Mohr, Lukas Geisler, Alexander Wree, Jana Knorr, Münevver Demir, Mihael Vucur, Sven H. Loosen, Fabian Benz, Markus Reiss, Bertram Wiedenmann, Frank Tacke, Henning Jann, Teresa Hellberg, Christoph Roderburg
Published 2020-09-01